Let's talk about what we know about cosmetic surgery. First, it's costly. It's invasive, leaves scars, and has long recovery times. Cosmetic surgery is mostly for the rich and famous -- not regular ...
InMode shares experienced a significant drop of 20% in one trading day, but the decline is seen as excessively harsh. InMode's unique product line bridges the gap between surgical procedures and ...
InMode is a medical device maker that specializes in minimally invasive treatments with results that resemble those of liposuction. The average price target on Wall Street for InMode represents a 47% ...
We recently compiled a list of the 10 Best Cosmetic Surgery and Aesthetics Stocks To Buy. In this article, we are going to take a look at where InMode Ltd. (NASDAQ:INMD) stands against the other ...
The U.S. Food and Drug Administration said in a statement that it is making consumers, patients, and health care providers aware that serious ...
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...
Shares of medical-device company InMode (NASDAQ: INMD) surged on Thursday after the company reported financial results for the second quarter of 2022. The company keeps beating expectations, and ...
InMode Ltd. recently reaffirmed its revenue guidance for the third quarter and full year 2025, expecting US$92.5 million to US$93.0 million for Q3 and US$365 million to US$375 million for the year, in ...
InMode machines provide a platform for noninvasive cosmetic procedures. The potential for new market entrants and lack of recurring revenue is concerning. Traditional cosmetic surgery is expensive, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback